The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,2-Bis(3-methyl-1-phenyl-1H-pyrazol-5-yl)disulfane ID: ALA2377172
PubChem CID: 9929673
Max Phase: Preclinical
Molecular Formula: C20H18N4S2
Molecular Weight: 378.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(SSc2cc(C)nn2-c2ccccc2)n(-c2ccccc2)n1
Standard InChI: InChI=1S/C20H18N4S2/c1-15-13-19(23(21-15)17-9-5-3-6-10-17)25-26-20-14-16(2)22-24(20)18-11-7-4-8-12-18/h3-14H,1-2H3
Standard InChI Key: NIJWTRSAOSNCDN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
12.4687 -12.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4718 -11.5811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7579 -11.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0406 -11.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0415 -12.4088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7559 -12.8195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7560 -13.6444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0890 -14.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3440 -14.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1695 -14.9137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4237 -14.1289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6549 -15.5807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3042 -13.8755 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9691 -14.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9679 -15.3684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6827 -15.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3991 -15.3680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3963 -14.5374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6809 -14.1283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6790 -13.3034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3449 -12.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0881 -12.0326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2626 -12.0351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0102 -12.8204 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7757 -11.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1303 -13.0691 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
6 7 1 0
10 12 1 0
8 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 20 1 0
19 20 1 0
23 25 1 0
21 26 1 0
26 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.53Molecular Weight (Monoisotopic): 378.0973AlogP: 5.47#Rotatable Bonds: 5Polar Surface Area: 35.64Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.20CX LogP: 5.19CX LogD: 5.19Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -0.90
References 1. Purohit MK, Scovell I, Neschadim A, Katsman Y, Branch DR, Kotra LP.. (2013) Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells., 23 (8): [PMID:23489619 ] [10.1016/j.bmcl.2013.02.064 ] 2. Purohit MK, Chakka SK, Scovell I, Neschadim A, Bello AM, Salum N, Katsman Y, Bareau MC, Branch DR, Kotra LP.. (2014) Structure-activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias., 22 (9): [PMID:24685704 ] [10.1016/j.bmc.2014.03.016 ]